Registration - Amendment
BOCKORNY GROUP, INC. for GLAXOSMITHKLINE
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues affecting the pharmaceutical industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOCKORNY New | — |
| ANDREW CHARLES DODSON New | — |
| DIANE MAJOR New | — |
| BRENDA REESE New | — |
| MELISSA SCHULMAN New | — |
| MICHAELA SIMS New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| GLAXOSMITHKLINE, PLC | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.